Introduction: Lipopolysaccharide (LPS) stimulates inflammation and cytokine production. LPS actions on intracellular signaling result in cytokine synthesis and are poorly understood, but phosphorylation plays a key role. Src tyrosine kinases are cytosolic, non-receptor tyrosine kinases in hematopoietic cells that phosphorylate and modulate signal transduction. Hypothesis: We hypothesized that selective inhibition of src tyrosine kinases with PP1 (4-amino-5-[4-methylphenyl)]-7-[t-butyl]pyrazolo[3,4-d]-pyrimidine) would attenuate the cytokine response post-LPS. Methods: Sprague-Dawley rats (14-18wk) were anesthetized, randomized to vehicle (0.05ml/kg DMSO IV, n=5) or PP1 (1.5mg/kg IV, n=6) then subject to LPS (20mg/kg IV). We measured levels of IL1α, 1β, 2, 4, 5, 6, 10, 12, 18, TNFα, IFNγ, GMCSF and MCP1 with a multiplex bead assay (Luminex) in serial (1h post-anesthesia, 0.5h post-vehicle/PP1 and 1, 2, and 3h post-LPS) serum samples. Heart rate and mean arterial blood pressure were recorded. Results: IL12 was attenuated by PP1 at 1 and 2h post-LPS while IL1α, 18 and MCP1 were attenuated by PP1 at 2h post-LPS. At 2 and 3h post-LPS, IL2 and 4 were attenuated by PP1 (all p<0.05 vs vehicle, Fisher's LSD). PP1 did not affect the response to LPS for IL1β, 5, 6, 10, TNFα and IFNγ. GMCSF was not detectable. Responses of tachycardia and hypotension post-LPS were similarly attenuated (tachycardia at 3h and hypotension at 2 and 3h; p<0.05, Fisher's LSD). Conclusions: These data suggest inhibition of src tyrosine kinases with PP1 attenuates the cytokine response to LPS and improves physiologic variables. To our knowledge, this is the first assessment of the effect of PP1 on the cytokine response to LPS in an animal model. Inhibition of src kinases may provide a novel therapeutic approach to managing septic shock. Support: Laerdal Foundation
